{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:08:25Z","timestamp":1793815705985,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013043","name":"Yale Center for Clinical Investigation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013048","name":"CONNECTICUT MENTAL HEALTH CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013057","name":"Heffter Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006373","name":"Ohio Department of Mental Health and Addiction Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heliyon.2022.e12135","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:51:24Z","timestamp":1670295084000},"page":"e12135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report"],"prefix":"10.1016","volume":"8","author":[{"given":"Benjamin","family":"Kelmendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Kichuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"DePalmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-2237","authenticated-orcid":false,"given":"Terence H.W.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Belser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2117-9321","authenticated-orcid":false,"given":"Christopher","family":"Pittenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e12135_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/da.23212","article-title":"Transcranial direct current stimulation targeting the medial prefrontal cortex modulates functional connectivity and enhances safety learning in obsessive-compulsive disorder: results from two pilot studies","volume":"39","author":"Adams","year":"2022","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.heliyon.2022.e12135_bib2","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12135_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10608-018-9911-z","article-title":"Emotion Regulation in Patients with obsessive compulsive disorder: unique effects for those with \u201ctaboo thoughts","volume":"42","author":"Berman","year":"2018","journal-title":"Cognit. Ther. Res."},{"key":"10.1016\/j.heliyon.2022.e12135_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biopsych.2012.05.028","article-title":"Effects of ketamine in treatment-refractory obsessive-compulsive disorder","volume":"72","author":"Bloch","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"15","key":"10.1016\/j.heliyon.2022.e12135_bib5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12135_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatr."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12135_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12135_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12135_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12135_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.heliyon.2022.e12135_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.heliyon.2022.e12135_bib12","series-title":"5-Methoxy-N,N-dimethyltryptamine: an Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity","author":"Germann","year":"2019"},{"key":"10.1016\/j.heliyon.2022.e12135_bib13","doi-asserted-by":"crossref","first-page":"109406","DOI":"10.1016\/j.mehy.2019.109406","article-title":"The psilocybin-telomere hypothesis: an empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging","volume":"134","author":"Germann","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12135_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12135_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown obsessive compulsive scale. II. Validity","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12135_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.heliyon.2022.e12135_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin study for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.heliyon.2022.e12135_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12135_bib19","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.heliyon.2022.e12135_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"27","key":"10.1016\/j.heliyon.2022.e12135_bib21","doi-asserted-by":"crossref","first-page":"16959","DOI":"10.1021\/acsomega.0c02387","article-title":"Direct phosphorylation of psilocin enables optimized cGMP kilogram-scale manufacture of psilocybin","volume":"5","author":"Kargbo","year":"2020","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12135_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s41811-020-00075-6","article-title":"The emotional Schemas and obsessive-compulsive symptom dimensions in people with obsessive-compulsive disorder","volume":"13","author":"Khosravani","year":"2020","journal-title":"Int. J. Cognit. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12135_bib23","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s12144-018-9859-x","article-title":"Difficulties in emotion regulation and symptom dimensions in patients with obsessive-compulsive disorder","volume":"39","author":"Khosravani","year":"2020","journal-title":"Curr. Psychol."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12135_bib24","doi-asserted-by":"crossref","first-page":"1239a","DOI":"10.1176\/ajp.144.9.1239b","article-title":"Relief of obsessive-compulsive symptoms by LSD and psilocin","volume":"144","author":"Leonard","year":"1987","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12135_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/02791072.2020.1849879","article-title":"Long-term amelioration of OCD symptoms in a patient with chronic consumption of psilocybin-containing mushrooms","volume":"53","author":"Lugo-Radillo","year":"2021","journal-title":"J.\u00a0Psychoact. Drugs"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12135_bib26","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2022.e12135_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12135_bib28","doi-asserted-by":"crossref","first-page":"1037b","DOI":"10.1176\/ajp.154.7.1037b","article-title":"Hallucinogen-induced relief of obsessions and compulsions","volume":"154","author":"Moreno","year":"1997","journal-title":"Am. J. Psychiatr."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12135_bib29","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.heliyon.2022.e12135_bib30","first-page":"51","article-title":"Race as a component of set and setting: how experiences of race can influence psychedelic experiences","volume":"4","author":"Neitzke-Spruill","year":"2020","journal-title":"J.\u00a0Psych. Stud."},{"key":"10.1016\/j.heliyon.2022.e12135_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3928\/00485713-20150602-06","article-title":"Glutamate modulators in the treatment of obsessive-compulsive disorder","volume":"45","author":"Pittenger","year":"2015","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.heliyon.2022.e12135_bib32","series-title":"The Neurobiology and Treatment of OCD: Accelerating Progress","first-page":"331","article-title":"Pharmacotherapeutic strategies and new targets in OCD","author":"Pittenger","year":"2021"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12135_bib33","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12135_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12135_bib35","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1073\/pnas.1716686115","article-title":"Multivariate resting-state functional connectivity predicts response to cognitive behavioral therapy in obsessive\u2013compulsive disorder","volume":"115","author":"Reggente","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2022.e12135_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2021.03.002","article-title":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review","volume":"137","author":"Romeo","year":"2021","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12135_bib37","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.heliyon.2022.e12135_bib38","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.heliyon.2022.e12135_bib39","series-title":"Handbook of Psychiatric Measures","first-page":"113","article-title":"Sheehan disability scale","author":"Sheehan","year":"2000"},{"issue":"Suppl 20","key":"10.1016\/j.heliyon.2022.e12135_bib40","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.heliyon.2022.e12135_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.heliyon.2022.e12135_bib42","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12135_bib43","first-page":"109","article-title":"An initial examination of emotion regulation and obsessive-compulsive symptoms","volume":"3","author":"Stern","year":"2014","journal-title":"J.\u00a0Obsess. Compul. Relat. Disorder."},{"key":"10.1016\/j.heliyon.2022.e12135_bib44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J.\u00a0Humanist. Psychol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12135_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/02791072.2014.963754","article-title":"Psilocybin and obsessive-compulsive disorder","volume":"46","author":"Wilcox","year":"2014","journal-title":"J.\u00a0Psychoact. Drugs"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12135_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jclp.22553","article-title":"Emotion regulation difficulties in obsessive-compulsive disorder","volume":"74","author":"Yap","year":"2018","journal-title":"J.\u00a0Clin. Psychol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:52:58Z","timestamp":1767102778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022034235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2405844022034235"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12135","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e12135"}}